Cell therapy: optimizing the vein-to-vein workflow – an eBook
In this eBook, we delve further into the cell therapy workflow and highlight the patient as a focal point throughout this journey. We also explore how a GMP-compliant, semiautomated manufacturing platform can result in consistent, efficacious CAR T cell production.
Contents include:
- [FOREWORD] Welcome to our eBook on ‘Cell therapy: optimizing the vein-to-vein workflow’
- [INTERVIEW] From vendor to cell therapy partner: an interview with Xavier de Mollerat du Jeu, Thermo Fisher Scientific
- [APPLICATION NOTE] Autologous CAR T cell manufacturing using a semiautomatic, closed, modular workflow
- [INFOGRAPHIC] Cell therapy workflow: integrated solutions from collection to delivery
- [CELL THERAPY HANDBOOK]
- Raw material considerations for cell therapy manufacturing
- Cell therapy vendor qualification process
- [PERSPECTIVE] Improved harmonization of critical characterization assays across cell therapies
- [COMMENTARY] Development of a closed and automated bioreactor technology for cell therapy manufacturing – a sharing of our journey
To gain access and download this FREE eBook, complete the short form below:
In association with: